Skip to content
Showing 51 - 60 of 65 results.
COVID-19 tests are being processed each day by the Clinical Microbiology Lab at New York-Presbyterian/CUIMC to detect the presence of the virus in nasopharyngeal samples to determine infection.
The UK has invested heavily in newly developed home testing kits to test for antibodies to the SARS-CoV-2 virus. At issue is the sensitivity of the test and the levels of antibodies in the population.
Public health experts from China, Japan, Singapore, South Korea, and the U.S. discussed experiences and lessons learned from the front-line responses to COVID-19.
Dr. David Ho had a Q&A with members of the Caltech community to discuss the novel coronavirus and the future of our society in the light of this global pandemic.
Dr. Ho is leading four research teams at Columbia University to identify antivirals as well as monoclonal neutralizing antibodies that may be used to treat and prevent infection with SARS-CoV-2.
New York city is not only the U.S. epicenter of the SARS-CoV-2 pandemic, but it is also on the cutting edge research into understanding and identifying strategies to treat and prevent the infection.
Dr. David Ho, director of the ADARC, talks with Rachel Maddow about the consideration of existing drugs for the treatment of coronavirus infection and the prospects and timeline for an eventual cure.
Dr. David Ho is a world-renowned doctor and researcher on the frontlines of the current crisis. He joins Walter Isaacson to explain the lessons we should have learned from the 2003 SARS outbreak.
Dr. David Ho, director of ADARC, talks with Rachel Maddow about work being done to find a treatment for novel coronavirus infection. Researchers are hopeful to find an answer.
Remdesivir, a broad spectrum antiviral agent with activity against a broad range of RNA viruses including the SARS-CoV-2 virus, is considered a reasonable prospect of helping patients.